CARGO Therapeutics, Inc. (CRGX)

19.56 -0.82 (-4.02%) As of 12:24PM EDT. Market open.

CARGO Therapeutics, Inc.

1900 Alameda De Las Pulgas
Suite 350
San Mateo, CA 94403
United States
650-379-6143
https://cargo-tx.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 116

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Gina Chapman	President, CEO & Director	1.09M	N/A	1967
Dr. Crystal L. Mackall M.D.	Co-Founder	160k	N/A	1961
Mr. Anup Radhakrishnan	CFO, Secretary & Chief Business Officer	667.1k	N/A	1980
Dr. Ginna G. Laport M.D.	Chief Medical Officer	538.13k	N/A	1965
Dr. Robbie Majzner M.D.	Founder & Chair of Scientific Advisory Board	N/A	N/A	N/A
Ms. Nancy Goodman J.D.	Founder	N/A	N/A	N/A
Dr. Louai Labanieh	Founder	N/A	N/A	N/A
Mr. Faisal Shawwa M.B.A.	Senior Vice President of Finance & Accounting	N/A	N/A	N/A
Dr. Shishir Gadam Ph.D.	Chief Technical Officer	674.03k	N/A	1967
Dr. Michael Ports Ph.D.	Chief Scientific Officer	N/A	N/A	1981

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Corporate governance

CARGO Therapeutics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.